Iradimed (IRMD) Gross Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 124.00 |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 76.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.00 |
| Dec 31, 2025 | -43.00 |
| Sep 30, 2025 | -84.00 |
| Jun 30, 2025 | -153.00 |
| Mar 31, 2025 | -11.00 |
| Dec 31, 2024 | -178.00 |
| Sep 30, 2024 | 38.00 |
| Jun 30, 2024 | 340.00 |
| Mar 31, 2024 | -49.00 |
| Dec 31, 2023 | 151.00 |
| Sep 30, 2023 | 321.00 |
| Jun 30, 2023 | 299.00 |
| Mar 31, 2023 | 126.00 |
| Dec 31, 2022 | 67.00 |
| Sep 30, 2022 | 40.00 |
| Jun 30, 2022 | -15.00 |
| Mar 31, 2022 | 46.00 |
| Dec 31, 2021 | 168.00 |
| Sep 30, 2021 | 105.00 |
| Jun 30, 2021 | -207.00 |
| Mar 31, 2021 | 36.00 |
| Dec 31, 2020 | -19.00 |
| Sep 30, 2020 | -245.00 |
| Jun 30, 2020 | -510.00 |
| Mar 31, 2020 | 137.00 |
| Dec 31, 2019 | -341.00 |
| Sep 30, 2019 | -344.00 |
| Jun 30, 2019 | -252.00 |
| Mar 31, 2019 | -524.00 |
| Dec 31, 2018 | -673.00 |
| Sep 30, 2018 | -458.00 |
| Jun 30, 2018 | -450.00 |
| Mar 31, 2018 | -480.00 |
| Dec 31, 2017 | 117.00 |
| Sep 30, 2017 | 219.00 |
| Jun 30, 2017 | -384.00 |
| Mar 31, 2017 | -843.00 |
| Dec 31, 2016 | 568.00 |
| Sep 30, 2016 | 869.00 |
| Jun 30, 2016 | 1,004.00 |